Stocks Taking Toll on Profitability Valuation: Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH)

Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) share price swings at $0.41 with percentage change of -39.64% in most recent trading session.

Pool Consensus

Lets us look over what analysts have to say about performance of the ANTH. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $-0.38 as compared to the next year Q1 current trend of $-0.25. While on annual basis the current EPS estimates trend for FY 2017 came in for $-1.04 as compared to three months ago $-1.29.

The stock prices target chart showed high target of 3 kept by analysts at WSJ while the average price target was for 1.41 as compared to current price of 0.41. Somehow, the stock managed to gain BUY ratings by 2 analysts in current tenure as 1 analyst having overweight ratings, 3 recommend as HOLD. Overall, the consensus ratings were for Overweight by the pool of analysts.

While returns on assets calculated as -208.40% that gives an idea about how efficient management is at using its assets to generate earnings. Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) has returns on equity of -426.00%, which is measuring a corporation’s profitability by revealing how much profit generates by ANTH with the shareholders’ money. The firm attains analyst recommendation of 2.60 on scale of 1-5 with week’s performance of -29.72%.

Effective Investment Valuation

Furthermore, it has price to sale ratio of 179.64 that signifies the value placed on each dollar of a firm’s sales or incomes. The firm’s price to book was 5.18, which can be compared with current price to get idea about under or overvalue of stock. The float short ration was 16.54%; as compared to Short Ratio were 3.08. The firm has institutional ownership of 37.00%, while insider ownership included 0.10%.


About Richard Avery

He is a capital projects manager and process design engineer at a large-cap company. He has renowned MBA degree. Before joining SWR, he was a freelance writer for renounce tech websites. He is currently studying for CFP exam. Interests: Tech stocks, Economic Markets, Blue-chips.

Leave a Reply

Your email address will not be published. Required fields are marked *